First-in-Human Evaluation of Site-Specifically Labeled<sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer-Reference-Cited by-同舟云学术

First-in-Human Evaluation of Site-Specifically Labeled⁸⁹Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer

Published:2024-01-25 Issue:3 Volume:65 Page:386-393
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Yeh Randy,O’Donoghue Joseph A.,Jayaprakasam Vetri Sudar,Mauguen Audrey,Min Ryan,Park Sue,Brockway Julia P.,Bromberg Jacqueline F.,Zhi W Iris,Robson Mark E.,Sanford Rachel,Modi Shanu,Agnew Brian J.,Lyashchenko Serge K.,Lewis Jason S.,Ulaner Gary A.,Zeglis Brian M.

Publisher

Society of Nuclear Medicine

Reference30 articles.

1. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

2. Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

3. Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

4. Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

5. 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up;Bensch;Eur J Nucl Med Mol Imaging.,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-11

2. Radiotracer Innovations in Breast Cancer Imaging: A Review of Recent Progress;Diagnostics;2024-09-03

3. Site-specific bioconjugation and nuclear imaging;Current Opinion in Chemical Biology;2024-08

4. Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives;Current Opinion in Oncology;2024-06-13

5. PET imaging of Aspergillus infection using Zirconium-89 labeled anti-β-glucan antibody fragments;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-24